Results 31 to 40 of about 62,609,046 (216)

Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection

open access: yesCase Reports in Medicine, 2010
Here, we report the case of an HIV infected patient that was treated for pneumonia with a macrolid antibiotic. The patient experienced a prolongation of the already pathologic QTc interval resulting in repeated torsades de pointes necessitating CPR and ...
Alexander Shimabukuro-Vornhagen   +7 more
doaj   +1 more source

Torsades de Pointes

open access: yesJournal of Education and Teaching in Emergency Medicine, 2018
History of present illness: 70-year-old male with a history ventricular arrhythmia, AICD (automated implantable cardioverter defibrillator), coronary artery disease and cardiac stents presented to the Emergency Department after three AICD discharges ...
Richard J Chen, MD   +2 more
doaj   +1 more source

Hypocalcemic torsades de pointes

open access: yesJournal of Electrocardiology, 1989
Torsades de pointes is a unique form of ventricular tachycardia that occurs in the presence of prolonged QT interval. Many predisposing factors have been identified. A classical form of torsades de pointes occurring in the presence of hypocalcemia and prolonged QT interval in an elderly woman is reported.
T, Akiyama   +4 more
openaire   +2 more sources

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation

open access: yesIndian Pacing and Electrophysiology Journal, 2017
A 79-year-old woman who underwent catheter ablation for paroxysmal atrial fibrillation presented with Torsades de Pointes (TdP). Aggravation of prolonged QT interval which is most likely due to neural modulation by catheter ablation, played major role in
Yae Min Park   +6 more
doaj   +1 more source

Focal and Reentrant Mechanisms of Torsades de Pointes: EAD, Reentry, or Chimera?

open access: yesJournal of Arrhythmia, 2011
Torsades de pointes (TdP. is characterized not only by its electrocardiographic morphology but also by a tendency to spontaneously terminate.
Yuji Murakawa, MD
doaj   +1 more source

Iron Overload Leading to Torsades de Pointes in β-Thalassemia and Long QT Syndrome [PDF]

open access: yes, 2016
The authors present a unique case of torsades de pointes in a β-thalassemia patient with early iron overload in the absence of any structural abnormalities as seen in hemochromatosis.
Schmitt, Nicole   +9 more
core   +1 more source

Dilated Cardiomyopathy Compatible With Sarcoidosis Presenting with Syncope Due to Torsades de Pointes: a Case Report

open access: yesJournal of Cardiac Arrhythmias, 2020
Sarcoidosis is a multisystemic noncaseating granulomatous disease of unknown etiology. Cardiac sarcoidosis clinical presentation is diverse, and syncope is one of the possible primary events.
Carollina Fernandes Tinoco   +4 more
doaj   +4 more sources

Torsades de Pointes pada pasien Hipokalemia: Peranan Afterdepolarization pada mekanisme Takiaritmia

open access: yesMajalah Kardiologi Indonesia, 2014
Kasus Seorang wanita usia 56 tahun, dengan riwayat gagaljantung dalam pengobatan dengan obat diuretik furosemid, mengalami muntaber selama 3 hari terakhir.
Alexander Tondas, Yoga Yuniadi
doaj   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun   +4 more
wiley   +1 more source

Risk of Cardiac Lesion with Chronic and Acute Use of Loperamide—An Integrative Review

open access: yesJournal of Cardiovascular Development and Disease, 2022
Loperamide is a synthetic opioid commonly used as an antidiarrheal due to its activation of u-opioid receptors in the myenteric plexus. In therapeutic doses, it inhibits peristalsis and has anti-secretory and anti-motility effects, until metabolized by ...
Bruna Cremonezi Lammoglia   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy